Results 11 to 20 of about 286,873 (209)

Intravitreal Dexamethasone Implant (Ozurdex) in Coats' Disease [PDF]

open access: yesCase Reports in Ophthalmology, 2013
We injected an intravitreal dexamethasone implant in two eyes of 2 pediatric patients with Coats' disease in addition to other treatment modalities, such as intravitreal ranibizumab injection and indirect laser photocoagulation. In both eyes, intraocular
Ali Osman Saatci   +2 more
doaj   +5 more sources

Dexamethasone intravitreal implant in the treatment of diabetic macular edema

open access: yesClinical Ophthalmology, 2015
Pravin U Dugel,1,2 Francesco Bandello,3 Anat Loewenstein4 1Retinal Consultants of Arizona, Phoenix, AZ, 2Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; 3Department of Ophthalmology ...
Dugel PU, Bandello F, Loewenstein A
doaj   +7 more sources

Acute bacterial endophthalmitis following dexamethasone intravitreal implant: A case report

open access: yesSaudi Journal of Medicine and Medical Sciences, 2019
A 54-year-old male presented to our ophthalmology clinic with a diagnosis of the right central retinal vein occlusion with macular edema. The patient was treated with dexamethasone intravitreal implant. Three days after the implant insertion, the patient
Waseem Al Zamil, Sanaa A Yassin
doaj   +2 more sources

Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema

open access: yesCase Reports in Ophthalmology, 2013
Purpose: To report the efficacy of intravitreal dexamethasone implant in a patient with retinitis pigmentosa and bilateral cystoid macular edema unresponsive to topical carbonic anhydrase inhibitors.
Ali Osman Saatci   +3 more
doaj   +2 more sources

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant

open access: yesClinical Ophthalmology, 2010
Jane S Myung, Grant D Aaker, Szilárd KissDepartment of Ophthalmology, Weill Cornell Medical Center, New York, NY, USAPurpose: To report our experience with dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan,
Jane S Myung   +2 more
doaj   +2 more sources

Acute Onset of Exogenous Endophthalmitis after Dexamethasone Implant Injection Treated without Implant Removal

open access: yesCase Reports in Ophthalmological Medicine, 2018
We present a case of acute endophthalmitis after intravitreal dexamethasone implant injection and discuss the management of this rare and challenging case in which the implant could not be removed.
George G. Bastakis   +4 more
doaj   +2 more sources

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®) [PDF]

open access: yesCase Reports in Ophthalmological Medicine, 2017
Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion.
Erdem Eris   +5 more
doaj   +2 more sources

Comparative characteristics of the outcomes of the use of multidirectional intravitreal pharmacotherapy in the treatment of diabetic macular edema

open access: yesОфтальмохирургия, 2021
Purpose. To conduct a comparative analysis of the effectiveness of intravitreal injection of dexamethasone-containing implant and aflibercept in macular edema in patients with diabetes mellitus.Material and methods.
M. M. Bikbov   +3 more
doaj   +3 more sources

Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report

open access: yesIndian Journal of Ophthalmology, 2012
We report on the significant improvement of central macular thickness in a case of clinically significant macular edema after dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex®; Allergan, Inc, Irvine, CA, USA).
Ashish Sharma   +4 more
doaj   +2 more sources

Intravitreal slow-releasing dexamethasone implant for idiopathic neuroretinitis

open access: yesEuropean Journal of Ophthalmology, 2020
Introduction: The purpose of this report is to describe a successful management of idiopathic neuroretinitis with intravitreal dexamethasone implant. Method: Interventional case report.
Osman Çekiç, Samet Gülkaş
openaire   +4 more sources

Home - About - Disclaimer - Privacy